Cite
MLA Citation
Sarmad Sadeghi et al.. “EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.” Journal of clinical oncology, vol. 41, no. 3, 2023, pp. 640–650. http://access.bl.uk/ark:/81055/vdc_100174260072.0x000002
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sarmad Sadeghi et al.. “EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.” Journal of clinical oncology, vol. 41, no. 3, 2023, pp. 640–650. http://access.bl.uk/ark:/81055/vdc_100174260072.0x000002